Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debanjali Mitra

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|November 29, 2021
Real-world treatment of patients with palbociclib for HR+/HER2-advanced/metastatic breast cancer: the Europe IRIS studyKatie Mycock, Lin Zhan, Kieran Hart, et al.
Journal of Global Oncology|May 4, 2019
Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving Palbociclib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer in Argentina: The IRIS StudyJohn Waller, Debanjali Mitra, Katie Mycock, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|November 3, 2012
Health and economic consequences of fragile X syndrome for caregiversDonald B Bailey, Melissa Raspa, Ellen Bishop, et al.
Current Medical Research and Opinion|May 3, 2017
Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysisCostel Chirila, Debanjali Mitra, Ann Colosia, et al.
European Journal of Pediatrics|February 27, 2013
Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patternsPaul Hodgkins, Juliana Setyawan, Debanjali Mitra, et al.
The Journal of Dermatology|December 13, 2023
Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experimentTommi Tervonen, Chiara Whichello, Ernest Law, et al.
Future Oncology (London, England)|November 10, 2020
Treatment patterns and clinical outcomes of palbociclib-based therapy received in US community oncology practicesJunji Lin, Lynn McRoy, Maxine D Fisher, et al.
Journal of Comparative Effectiveness Research|February 25, 2021
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancerHope S Rugo, Anja Haltner, Lin Zhan, et al.
Clinical Breast Cancer|May 21, 2019
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR<sup>+</sup>/HER2<sup>-</sup> Advanced Breast Cancer Enrolled in an Expanded Access ProgramAdam Brufsky, Debanjali Mitra, Keith L Davis, et al.
Future Oncology (London, England)|March 5, 2021
CDK4/6 inhibitors in HR+/HER2- advanced/metastatic breast cancer: a systematic literature review of real-world evidence studiesNadia Harbeck, Meaghan Bartlett, Dean Spurden, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|November 29, 2021
Real-world treatment of patients with palbociclib for HR+/HER2-advanced/metastatic breast cancer: the Europe IRIS studyKatie Mycock, Lin Zhan, Kieran Hart, et al.
Journal of Global Oncology|May 4, 2019
Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving Palbociclib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer in Argentina: The IRIS StudyJohn Waller, Debanjali Mitra, Katie Mycock, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|November 3, 2012
Health and economic consequences of fragile X syndrome for caregiversDonald B Bailey, Melissa Raspa, Ellen Bishop, et al.
Current Medical Research and Opinion|May 3, 2017
Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysisCostel Chirila, Debanjali Mitra, Ann Colosia, et al.
European Journal of Pediatrics|February 27, 2013
Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patternsPaul Hodgkins, Juliana Setyawan, Debanjali Mitra, et al.
The Journal of Dermatology|December 13, 2023
Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experimentTommi Tervonen, Chiara Whichello, Ernest Law, et al.
Future Oncology (London, England)|November 10, 2020
Treatment patterns and clinical outcomes of palbociclib-based therapy received in US community oncology practicesJunji Lin, Lynn McRoy, Maxine D Fisher, et al.
Journal of Comparative Effectiveness Research|February 25, 2021
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancerHope S Rugo, Anja Haltner, Lin Zhan, et al.
Clinical Breast Cancer|May 21, 2019
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR<sup>+</sup>/HER2<sup>-</sup> Advanced Breast Cancer Enrolled in an Expanded Access ProgramAdam Brufsky, Debanjali Mitra, Keith L Davis, et al.
Future Oncology (London, England)|March 5, 2021
CDK4/6 inhibitors in HR+/HER2- advanced/metastatic breast cancer: a systematic literature review of real-world evidence studiesNadia Harbeck, Meaghan Bartlett, Dean Spurden, et al.
Pageof 5